The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Poster Session

Fri. Oct, 12

Poster Session 1-3 AML: Chromosomal and genetic mutations

Fri. Oct 12, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Keisuke Kataoka (Division of Moleculor Oncology, National Cancer Center Researchinstitute)

[PS1-3-6] Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia

Seiji Kakiuchi1, Rina Sakai2, Koji Kawaguchi2, Ako Higashime2, Keiji Kurata2, Hiroya Ichikawa2, Shigeki Nagao3, Junpei Rikitake1, Naomi Kiyota2, Kimikazu Yakushijin2, Hiroshi Matsuoka2, Hironobu Minami2 (1.Department of Hematology, Yodogawa Christian Hospital, Osaka, Japan., 2.Department of Medical Oncology/Hematology, Kobe University Hospital, Kobe, Japan, 3.Division of Hematology, National Defense Medical College Hospital, Tokorozawa, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password